Tarui disease and distal glycogenoses: clinical and genetic update.

Phosphofructokinase deficiency (Tarui disease) was the first disorder recognized to directly affect glycolysis. Since the discovery of the disease, in 1965, a wide range of biochemical, physiological and molecular studies have greatly contributed to our knowledge concerning not only phosphofructokinase function in normal muscle but also on the general control of glycolysis and glycogen metabolism. Studies on phosphofructokinase deficiency vastly enriched the field of glycogen storage diseases, making a relevant improvement also in the molecular genetic area. So far, more than one hundred patients have been described with prominent clinical symptoms characterized by muscle cramps, exercise intolerance, rhabdomyolysis and myoglobinuria, often associated with haemolytic anaemia and hyperuricaemia. The muscle phosphofructokinase gene is located on chromosome 12 and about 20 mutations have been described. Other glycogenoses have been recognised in the distal part of the glycolytic pathway: these are infrequent but some may induce muscle cramps, exercise intolerance and rhabdomyolysis. Phosphoglycerate Kinase, Phosphoglycerate Mutase, Lactate Dehydrogenase, beta-Enolase and Aldolase A deficiencies have been described as distal glycogenoses. From the molecular point of view, the majority of these enzyme deficiencies are sustained by "private" mutations.
AuthorsA Toscano, O Musumeci
JournalActa myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases (Acta Myol) Vol. 26 Issue 2 Pg. 105-7 (Oct 2007) ISSN: 1128-2460 [Print] Italy
PMID18421897 (Publication Type: Journal Article, Review)
Chemical References
  • L-Lactate Dehydrogenase
  • Phosphofructokinases
  • Phosphoglycerate Kinase
  • Fructose-Bisphosphate Aldolase
  • Phosphopyruvate Hydratase
  • Phosphoglycerate Mutase
  • Anemia, Hemolytic (genetics)
  • Exercise Tolerance
  • Fructose-Bisphosphate Aldolase (deficiency)
  • Glycogen Storage Disease (enzymology)
  • Glycogen Storage Disease Type VII (complications, diagnosis, enzymology, genetics)
  • Humans
  • Hyperuricemia (genetics)
  • L-Lactate Dehydrogenase (deficiency)
  • Muscle Cramp (genetics)
  • Mutation
  • Myoglobinuria (genetics)
  • Phosphofructokinases (deficiency, genetics)
  • Phosphoglycerate Kinase (deficiency)
  • Phosphoglycerate Mutase (deficiency)
  • Phosphopyruvate Hydratase (deficiency)
  • Rhabdomyolysis (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: